Effect of tramadol use on three point-of-care and one instrument-based immunoassays for urine buprenorphine

Journal of Analytical Toxicology

Volumn 32, Issue 5, 2008, Pages 339-343

  Shaikh, Salima ^a,b   Hull, Mindy J ^a,b   Bishop, Kenneth A ^a   Griggs, David A ^a   Long, William H ^a   Nixon, Andrea L ^a   Flood, James G ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; NORBUPRENORPHINE; TRAMADOL;

ACON DEVICE; ARTICLE; CALIBRATION; CLINICAL ARTICLE; CROSS REACTION; DRUG EFFECT; FALSE POSITIVE RESULT; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MEDICAL INSTRUMENTATION; POINT OF CARE TESTING; SCREENING TEST; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 45849108723     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.5.339     Document Type: Article

References (11)

1. P.A. Donaher and C. Welsh. Managing opioid addiction with buprenorphine. Am. Fam. Physician 73: 1573-1578 (2006).
2. M. Böttcher and O. Beck. Evaluation of buprenorphine CEDIA assay versus GC-MS and ELISA using urine samples from patients in substitution treatment. J. Anal. Toxicol. 29: 769-776 (2005).
3. M. Pavlic, K. Libiseller, P. Grubwieser, and W. Rabl. Cross-reactivity of the cedia buprenorphine assay with opiates: an Austrian phenomenon? Int. J. Legal Med. 119: 378-381 (2005).
4. S. Grond and A. Sablotzki. Clinical pharmacology of tramadol. Clin. Pharmacokinet. 43: 879-923 (2004).
5. K. Minami, Y. Uezono, and Y. Ueta. Pharmacological aspects of the effects of tramadol on G-protein coupled receptors. J. Pharmacol. Sci. 103: 253-260 (2007).
6. E.H. Adams, S. Breiner, T.J. Cicero, A. Geller, J.A. Inciardi, S.H. Schnoll, E.C. Senay, and G.E. Woody. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain. J. Pain Symptom Manage. 31: 465-476 (2006).
7. Microgenics Cross-Reactivity Guide. http://www.Microgenics.com/CR Guide, October 2006.
8. P.R. Puopolo, S.A. Volpicelli, D.M. Johnson, and J.G. Flood. Emergency toxicology testing (detection, confirmation, and quantification) of basic drugs in serum by liquid chromatography with photodiode array detection. Clin. Chem. 37: 2124-2130 (1991).
9. S. Melanson. Implementing drug-of-abuse testing at the point of care: device characteristics and decision criteria with selected emphasis on the biosite triage system. Point of Care 4: 123-127 (2005).
10. R.C. Baselt. Disposition of Toxic Drugs and Chemicals in Man, 7th ed. Biomedical Publications, Foster City, CA, 2004, pp 1128-1131.
11. K.A. Moore, S.J. Cina, R. Jones, D.M. Selby, B. Levine, and M.L. Smith. Tissue distribution of tramadol and metabolites in an overdose fatality. Am. J. Forensic Med. Pathol. 20: 98-100 (1999).